title: GSK1265744 demonstrates robust in vitro activity against various clades of HIV-1.
authors.affiliation: *Aaron Diamond AIDS Research Center, New York, NY †The Rockefeller University, New York, NY ‡GlaxoSmithKline, Research Triangle Park, NC.
authors.forename: Sharon L
authors.initials: SL
authors.lastname: Karmon
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mohri
authors.forename: William
authors.initials: W
authors.lastname: Spreen
authors.forename: Martin
authors.initials: M
authors.lastname: Markowitz
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D011728:Pyridones / Q000494:pharmacology*; D054659:Diketopiperazines
chemical_list: D019380:Anti-HIV Agents; D011728:Pyridones; C584914:cabotegravir; D054659:Diketopiperazines